314 related articles for article (PubMed ID: 20926192)
1. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia.
Lawson KP; Nag S; Thompson AD; Mokha SS
Pain; 2010 Dec; 151(3):806-815. PubMed ID: 20926192
[TBL] [Abstract][Full Text] [Related]
2. Estrogen facilitates and the kappa and mu opioid receptors mediate antinociception produced by intrathecal (-)-pentazocine in female rats.
Robinson DL; Nag S; Mokha SS
Behav Brain Res; 2016 Oct; 312():163-8. PubMed ID: 27312267
[TBL] [Abstract][Full Text] [Related]
3. Activation of opioid receptor like-1 receptor in the spinal cord produces sex-specific antinociception in the rat: estrogen attenuates antinociception in the female, whereas testosterone is required for the expression of antinociception in the male.
Claiborne J; Nag S; Mokha SS
J Neurosci; 2006 Dec; 26(50):13048-53. PubMed ID: 17167094
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific modulation of spinal nociception by alpha2-adrenoceptors: differential regulation by estrogen and testosterone.
Thompson AD; Angelotti T; Nag S; Mokha SS
Neuroscience; 2008 Jun; 153(4):1268-77. PubMed ID: 18434028
[TBL] [Abstract][Full Text] [Related]
5. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms.
Dawson-Basoa ME; Gintzler AR
Pain; 1996 Jan; 64(1):169-177. PubMed ID: 8867260
[TBL] [Abstract][Full Text] [Related]
7. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
[TBL] [Abstract][Full Text] [Related]
8. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T
Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150
[TBL] [Abstract][Full Text] [Related]
10. The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Zamarripa CA; Pareek T; Schrock HM; Prisinzano TE; Blough BE; Sufka KJ; Freeman KB
Psychopharmacology (Berl); 2021 Dec; 238(12):3463-3476. PubMed ID: 34430992
[TBL] [Abstract][Full Text] [Related]
11. Long-term voluntary access to running wheels decreases kappa-opioid antinociception.
D'Anci KE; Gerstein AV; Kanarek RB
Pharmacol Biochem Behav; 2000 Jun; 66(2):343-6. PubMed ID: 10880688
[TBL] [Abstract][Full Text] [Related]
12. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
Lutfy K; Doan P; Nguyen M; Weber E
Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms.
Dawson-Basoa ME; Gintzler AR
Pain; 1996 Mar; 64(3):608-615. PubMed ID: 8783328
[TBL] [Abstract][Full Text] [Related]
14. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
Negus SS; Mello NK
Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
16. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint.
Clemente JT; Parada CA; Veiga MC; Gear RW; Tambeli CH
Neurosci Lett; 2004 Dec; 372(3):250-5. PubMed ID: 15542250
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
[TBL] [Abstract][Full Text] [Related]
18. Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats.
Stoffel EC; Ulibarri CM; Folk JE; Rice KC; Craft RM
J Pain; 2005 Apr; 6(4):261-74. PubMed ID: 15820914
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-dependent, sex-specific modulation of mustard oil-induced secondary thermal hyperalgesia by orphanin FQ in the rat.
Claiborne JA; Nag S; Mokha SS
Neurosci Lett; 2009 Jun; 456(2):59-63. PubMed ID: 19429134
[TBL] [Abstract][Full Text] [Related]
20. Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.
Huang P; Chen C; Cao D; Huang M; Liu-Chen LY
Neuropharmacology; 2022 Jan; 202():108860. PubMed ID: 34736959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
